Sweden · Delayed Price · Currency is SEK Genovis AB (publ.) Statistics
Total Valuation
STO:GENO has a market cap or net worth of SEK 1.12 billion. The enterprise value is 1.03 billion.
| Market Cap | 1.12B |
| Enterprise Value | 1.03B |
Important Dates
The last earnings date was Thursday, February 12, 2026.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:GENO has 66.06 million shares outstanding. The number of shares has increased by 0.48% in one year.
| Current Share Class | 66.06M |
| Shares Outstanding | 66.06M |
| Shares Change (YoY) | +0.48% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 14.53% |
| Owned by Institutions (%) | 5.49% |
| Float | 56.47M |
Valuation Ratios
The trailing PE ratio is 47.31 and the forward PE ratio is 38.41. STO:GENO's PEG ratio is 11.36.
| PE Ratio | 47.31 |
| Forward PE | 38.41 |
| PS Ratio | 8.61 |
| PB Ratio | 4.11 |
| P/TBV Ratio | 5.81 |
| P/FCF Ratio | 36.68 |
| P/OCF Ratio | 34.87 |
| PEG Ratio | 11.36 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.21, with an EV/FCF ratio of 33.72.
| EV / Earnings | 43.68 |
| EV / Sales | 7.92 |
| EV / EBITDA | 22.21 |
| EV / EBIT | 30.25 |
| EV / FCF | 33.72 |
Financial Position
The company has a current ratio of 7.36, with a Debt / Equity ratio of 0.27.
| Current Ratio | 7.36 |
| Quick Ratio | 5.81 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 1.84 |
| Debt / FCF | 2.40 |
| Interest Coverage | 27.04 |
Financial Efficiency
Return on equity (ROE) is 9.41% and return on invested capital (ROIC) is 13.23%.
| Return on Equity (ROE) | 9.41% |
| Return on Assets (ROA) | 4.85% |
| Return on Invested Capital (ROIC) | 13.23% |
| Return on Capital Employed (ROCE) | 7.83% |
| Weighted Average Cost of Capital (WACC) | 15.03% |
| Revenue Per Employee | 3.60M |
| Profits Per Employee | 652,722 |
| Employee Count | 36 |
| Asset Turnover | 0.37 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, STO:GENO has paid 3.31 million in taxes.
| Income Tax | 3.31M |
| Effective Tax Rate | 12.35% |
Stock Price Statistics
The stock price has decreased by -40.34% in the last 52 weeks. The beta is 2.12, so STO:GENO's price volatility has been higher than the market average.
| Beta (5Y) | 2.12 |
| 52-Week Price Change | -40.34% |
| 50-Day Moving Average | 20.16 |
| 200-Day Moving Average | 23.21 |
| Relative Strength Index (RSI) | 32.97 |
| Average Volume (20 Days) | 96,846 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:GENO had revenue of SEK 129.65 million and earned 23.50 million in profits. Earnings per share was 0.36.
| Revenue | 129.65M |
| Gross Profit | 115.85M |
| Operating Income | 27.39M |
| Pretax Income | 26.81M |
| Net Income | 23.50M |
| EBITDA | 39.67M |
| EBIT | 27.39M |
| Earnings Per Share (EPS) | 0.36 |
Balance Sheet
The company has 163.19 million in cash and 73.08 million in debt, with a net cash position of 90.11 million or 1.36 per share.
| Cash & Cash Equivalents | 163.19M |
| Total Debt | 73.08M |
| Net Cash | 90.11M |
| Net Cash Per Share | 1.36 |
| Equity (Book Value) | 271.52M |
| Book Value Per Share | 4.11 |
| Working Capital | 178.55M |
Cash Flow
In the last 12 months, operating cash flow was 32.02 million and capital expenditures -1.58 million, giving a free cash flow of 30.44 million.
| Operating Cash Flow | 32.02M |
| Capital Expenditures | -1.58M |
| Free Cash Flow | 30.44M |
| FCF Per Share | 0.46 |
Margins
Gross margin is 89.36%, with operating and profit margins of 21.13% and 18.12%.
| Gross Margin | 89.36% |
| Operating Margin | 21.13% |
| Pretax Margin | 20.68% |
| Profit Margin | 18.12% |
| EBITDA Margin | 30.60% |
| EBIT Margin | 21.13% |
| FCF Margin | 23.48% |
Dividends & Yields
STO:GENO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.48% |
| Shareholder Yield | -0.48% |
| Earnings Yield | 2.10% |
| FCF Yield | 2.73% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 4, 2012. It was a reverse split with a ratio of 0.1.
| Last Split Date | Apr 4, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |